Stereotaxis (STXS) Common Equity (2010 - 2026)
Stereotaxis' (STXS) quarterly Common Equity came in at $14.4 million in Q1 2026, up 398.54% year-over-year from $2.9 million in Q1 2025, and up 6.51% quarter-over-quarter from $13.5 million in Q4 2025.
Analysis
Stereotaxis (STXS) Common Equity (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Common Equity for 17 consecutive years, with $14.4 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Common Equity rose 398.54% year-over-year to $14.4 million in Q1 2026; TTM through Mar 2026 was $14.4 million, a 398.54% increase from a year earlier, with the FY2025 full-year figure at $13.5 million, up 121.73% from the prior year.
- Common Equity was $14.4 million for Q1 2026 at Stereotaxis, up from $13.5 million in the prior quarter.
- Over five years, Common Equity peaked at $32.3 million in Q1 2022 and troughed at $1.5 million in Q2 2025.
- A 5-year average of $16.3 million and a median of $14.6 million in 2024 frame the typical range for Common Equity.
- Across the five-year window, Common Equity sank 87.18% in 2025 and surged 398.54% in 2026, its largest moves.
- Over 5 years, Common Equity stood at $26.3 million in 2022, then plunged by 37.97% to $16.3 million in 2023, then sank by 62.8% to $6.1 million in 2024, then surged by 121.73% to $13.5 million in 2025, then advanced by 6.51% to $14.4 million in 2026.
- The last three Common Equity figures came in at $14.4 million (Q1 2026), $13.5 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 14.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 14.36 Mn |
| Dec 31, 2025 | 13.48 Mn |
| Sep 30, 2025 | 6.27 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 6.08 Mn |
| Sep 30, 2024 | 10.82 Mn |
| Jun 30, 2024 | 11.36 Mn |
| Mar 31, 2024 | 14.57 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 18.72 Mn |
| Jun 30, 2023 | 21.39 Mn |
| Mar 31, 2023 | 23.71 Mn |
| Dec 31, 2022 | 26.35 Mn |
| Sep 30, 2022 | 27.77 Mn |
| Jun 30, 2022 | 29.94 Mn |
| Mar 31, 2022 | 32.32 Mn |
| Dec 31, 2021 | 33.84 Mn |
| Sep 30, 2021 | 34.57 Mn |
| Jun 30, 2021 | 36.47 Mn |